Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCAP-XX Regulatory News (CPX)

Share Price Information for CAP-XX (CPX)

Share Price is delayed by 15 minutes
Get Live Data
0.295    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.03 (10.714%)
Market Cap: £17.10m
CPX Live PriceLast checked at - London Stock Exchange

Intraday CAP-XX Share Chart

Interim Results

1 Feb 2024 07:00

RNS Number : 6148B
CAP-XX Limited
01 February 2024
Β 

Dissemination of a Regulatory Announcement that contains inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310

Β 

1 February 2024

Β 

CAP-XX Limited

("CAP-XX" or the "Company")

Β 

Interim Results for the half-year ended 31 December 2023

Β 

Β 

CAP-XX Limited, a world leader in the design and manufacture of thin, flat supercapacitors and energy management systems, announces its interim results for the half-year ended 31 December 2023.

Β 

Key highlights

Β 

Β· Total revenue of approximately A$2.3m, an increase of 40% versus the comparative period (H1FY2023: A$1.6m)

Β· No license revenue recorded for the period (H1FY2023 : A$187K) but product sales increased by 59% versus the comparative period to A$2.3m (H1FY2023: A$1.4m), reflecting the greater focus by the Company on those revenues

Β 

Β· Average product gross margin increased to 35.7% (H1FY2023: 28.8%)

Β 

Β· Sales order book at 31 December 2023 was 33% higher than at 1 January 2023

Β 

Β· Continuing to add new distributors to broaden sales channels

Β 

Β· Adjusted EBITDA* loss of A$1,077k (H1FY2023: Adjusted EBITDA* loss of A$966k)

Β 

Β· On 15 December 2023, certain CAP-XX patents were deemed invalid by the United States District Court for the District of Delaware. CAP-XX has since lodged a motion to appeal the decision

Β 

Β· Cash reserves as at 31 December 2023 were A$0.3m with no debt. In addition, the Company has an unused line of credit of approximately A$1.5m.

* Adjusted EBITDA excludes patent infringement costs

Β 

CAP-XX Chairman, Pat Elliott and CEO, Lars Stegmann said:Β 

"Our half-year results reflect resilience in the face of industry challenges in the passive electronic market, achieving +59% growth on product revenue versus H1FY23. Key strategic initiatives, including a new salesforce as well as new distributor integration and market-focused approaches, position us for sustained success. This is underlined by a 33% growth in our sales bookings. The book-to-bill ratio remains above one and our progressive pipeline remains strong.

"Excitingly, partnerships with Ionic Industries and international universities for graphene technologies are underway, enhancing our innovation roadmap.

"The legal costs and unexpected expenses in relation to the departure of the former CEO and investment in new product developments have result in our adjusted EBITDA remaining negative and the Company's cash position being tight. However, the Board is managing the Company's cashflows carefully."

Β 

Electronic copies of CAP-XX's interim results for the half-year ended 31 December 2023 will shortly be available from the Company's website: www.cap-xx.com.

Β 

For further information contact:

Β 

CAP-XX Limited

Lars Stegmann (Chief Executive Officer) +61 (0) 2 9157 0000

Β 

Kreab (Financial PR)

Robert Speed +44 (0) 20 7074 1800

Β 

Allenby Capital (Nominated Adviser and Joint Broker)

David Hart / Piers Shimwell (Corporate Finance) +44 (0) 20 3328 5656

Tony Quirke / Stefano Aquilino (Sales and Corporate Broking)

Β 

Cavendish Capital Markets plc (Joint Broker)

Neil McDonald / Pearl Kellie +44 (0) 13 1220 6939

Β 

Β 

Β 

More information is available at www.cap-xx.com

Β 

Notes to Editors:

Β 

CAP-XX (LSE: CPX) is a world leader in the design and manufacture of thin, flat supercapacitors and energy management systems used in portable and small-scale electronic devices, and to an increasing extent, in larger applications such as automotive and renewable energy. The unique feature of CAP-XX supercapacitors is their very high power density and high energy storage capacity in a space-efficient prismatic package. These attributes are essential in power-hungry consumer and industrial electronics, and deliver similar benefits in automotive and other transportation applications. For more information about CAP-XX, visitΒ www.cap-xx.com

Β 

Β 

Β 

CAP-XX Limited

Consolidated statement of profit or loss

For the half-year ended 31 December 2023

Β 

Consolidated

Β 

Notes

Half-year 2023

Half-year 2022

Β 

Β 

Β 

Currency: Australian Dollars

Β 

$

$

Revenue from sale of goods and services

Β 

2,263,636

1,613,684

Cost of sale of goods and services

Β (1,455,452)

Β (1,015,774)

Gross margin (loss) on sale of goods and services

808,184

597,910

Other revenue

Β 

4,869

456

Other income

Β 

1,038,810

1,103,384

General and administrative expenses

(1,298,477)

(1,063,597)

Legal Expenses

(1,624,502)

(727,918)

Process and engineering expenses

(703,248)

(676,629)

Selling and marketing expenses

(405,728)

(407,085)

Research and development expenses

(885,494)

(900,223)

Share based payments

(206,251)

(387,326)

Other expenses

(159,725)

(111,800)

(Loss) before income tax

(3,431,562)

(2,572,828)

Income tax benefit/(expense)

-

-

Net loss after income tax for the half year

(3,431,562)

(2,572,828)

Β 

Β 

Β 

(Loss) attributable to members of CAP-XX Limited

Β 

(3,431,562)

(2,572,828)

Β 

Β 

Β 

Loss per share attributable to the ordinary equity holders of the company

Cents

Cents

Basic loss per share

(0.46)

(0.57)

Diluted loss per share

(0.46)

(0.57)

Β 

CAP-XX Limited

Consolidated statement of comprehensive income

For the half year ended 31 December 2023

Β 

Β 

Consolidated

Β 

Β 

Β 

2023

2022

Β 

Currency: Australian Dollars

Notes

$

$

Β 

Loss for the half year

(3,431,562)

(2,572,828)

Β 

Other comprehensive income

Β 

Items that may be reclassified subsequently to profit or loss

Β 

Β 

Β 

Exchange differences on translation of foreign operations

57,871

(5,108)

Β 

Other comprehensive loss for the half year, net of tax

(57,871)

(5,108)

Β 

Total comprehensive loss for the half year attributable to owners of CAP-XX Limited

(3,373,691)

(2,577,936)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

CAP-XX Limited

Consolidated statement of financial position

As at 31 December 2023

Β 

Consolidated

Notes

31 December 2023

30 June 2023

31 December 2022

Currency: Australian Dollars

Β 

$

$

$

Β 

Β 

Β 

Β 

ASSETS

Current assets

Cash and cash equivalents

328,630

2,643,810

494,839

Receivables

608,212

959,515

567,760

Inventories

2,396,026

2,201,906

2,300,272

Other

1,234,018

2,429,946

1,097,305

Total current assets

Β 

4,566,886

8,235,177

4,460,176

Β 

Non-current assets

Property, plant and equipment

2,238,246

2,428,233

2,626,643

Right of Use Assets

2,019,071

2,193,777

2,372,360

Other

204,808

204,808

204,808

Total non-current assets

4,462,125

4,826,818

5,203,811

Β 

TOTAL ASSETS

9,029,011

13,061,995

9,663,987

Β 

Β 

Β 

LIABILITIES

Current liabilities

Payables

1,902,848

1,833,557

1,035,285

Lease Liabilities

178,953

194,888

205,128

Provisions

732,672

632,655

801,016

Interest bearing liabilities

-

1,038,054

-

Total current liabilities

2,814,473

3,699,154

2,041,429

Non-current liabilities

Β 

Lease Liabilities

1,920,194

2,024,584

2,095,836

Provisions

785,862

803,910

770,957

Total non-current liabilities

2,706,056

2,828,494

2,866,793

TOTAL LIABILITIES

5,520,529

6,527,648

4,908,222

Β 

NET ASSETS

3,508,482

6,534,347

4,755,765

EQUITY

Β 

Β 

Β 

Β 

Contributed equity

119,317,434

119,175,769

114,615,217

Reserves

Β 

8,364,352

8,100,320

7,895,991

Accumulated losses

Β 

(124,173,304)

(120,741,742)

(117,755,443)

Β 

TOTAL EQUITY

3,508,482

6,534,347

4,755,765

Β 

Β 

Β 

CAP-XX Limited

Consolidated statements of changes in equity

For the half-year ended 31 December 2023

Consolidated

Β 

Β 

Contributed

Equity

$

Reserve

$

Accumulated losses

$

Total

$

Β 

Β 

Β 

Balance at 1 July 2022

114,511,790

7,513,773

(115,182,615)

6,842,948

Loss for the period as reported in the 2023 financial statements

-Β 

(5,559,127)

(5,559,127)

Β 

Other comprehensive lossΒ 

Β 

-Β 

(27,433)

-

Β 

(27,433)

Transactions with owners in their capacity as owners:

Contributions of equity, net of transaction costs and tax

4,663,979

4,663,979

Employee share options ? value of employee services

Β 

Β 

-

613,980

-

613,980

Balance at 30 June 2023

Β 

119,175,769

8,100,320

Β (120,741,742)

6,534,347

Β 

Profit for the period as reported in the 2024 interim financial statements

Β 

-Β 

-

(3,431,562)

(3,431,562)

Other comprehensive incomeΒ 

-Β 

57,871

-

Β 

57,871

Transactions with owners in their capacity as owners:

Contributions of equity, net of transaction costs and tax

141,665

Β -Β 

Β -Β 

103,428

Employee share options ? value of employee services

-

206,251

-

387,326

Balance at 31 December 2023

119,317,434

8,364,352

Β (124,173,304)

3,508,482

Β 

Β 

Β 

Β 

Β 

CAP-XX Limited

Consolidated statement of cash flows

For the half-year ended 31 December 2023

Β 

Consolidated

Β 

Β 

Β 

2023

2022

Currency: Australian Dollars

Notes

$

$

Cash flows from operating activities

Receipts from customers (inclusive of goods and services tax)

2,632,708

2,180,265

Payments to suppliers and employees (inclusive of goods and services tax)

(6,161,627)

Β (5,108,521)

(3,528,919)

(2,928,256)

Tax credit received

2,268,810

2,043,384

Interest paid on lease liabilities

(96,476)

(105,356)

Interest received

4,869

456

Net cash (outflow) from operating activities

(1,278,268)

(989,772)

Β 

Cash flows from investing activities

Β 

Payments for property, plant and equipment

(4,541)

(119,337)

Net cash (outflow) from investing activities

(4,541)

(119,337)

Β 

Β 

Β 

Cash flows from financing activities

Β 

Proceeds from issue of shares

141,665

103,428

Costs associated with the issue of shares

-

-

Proceeds from / (repayment of) borrowings

(1,038,054)

-

Principal repayments for lease liabilities

(120,316)

(109,086)

Net cash inflow from financing activities

(1,016,704)

(5,658)

Β 

Net (decrease) in cash and cash equivalents

(2,373,051)

Β 

(1,114,767)

Cash and cash equivalents at the beginning of the financial year

Β 

Β 

2,643,810

Β 

1,614,714

Effects of exchange rate changes on cash and cash equivalents

57,871

Β 

(5,108)

Cash and cash equivalents at the end of the financial year

Β 

Β 

328,630

Β 

494,839

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This general purpose interim financial report, for the half-year reporting period ended 31 December 2023, has been prepared in accordance with Australian equivalents to International Financial Reporting Standards (AIFRSs), other authoritative pronouncements of the Australian Accounting Standards Board, Urgent Issues Group Interpretations and the Corporations Act 2001. This general purpose interim financial report, for the half-year reporting period ended 31 December 2023, is unaudited.

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
IR EAAFFDDNLEAA
Date   Source Headline
31st Oct 20244:35 pmRNSProposed Fundraising
21st Oct 20249:57 amRNSUpdate re. final results and current trading
16th Oct 20247:00 amRNSContract Win
5th Sep 20247:00 amRNSTrading Update and Notice of Results
30th Aug 20245:00 pmRNSTotal Voting Rights
14th Aug 20247:12 amRNSGrant of options
6th Aug 20249:18 amRNSHolding(s) in Company
5th Aug 20247:00 amRNSExercise of warrants and total voting rights
29th Jul 20247:00 amRNSHolding(s) in Company
16th Jul 20247:00 amRNSMOU to establish technology partnership
18th Jun 20247:00 amRNSBoard Changes and Grant of Share Options
20th May 20247:00 amRNSHolding(s) in Company
13th May 20247:00 amRNSHolding(s) in Company
7th May 202410:10 amRNSHolding(s) in Company
7th May 20247:00 amRNSTrading Update
1st May 202411:08 amRNSHolding(s) in Company
30th Apr 20245:00 pmRNSTotal Voting Rights
25th Apr 20249:24 amRNSHolding(s) in Company
24th Apr 20245:04 pmRNSN05/24 - CAP-XX Limited - Restoration of trading
23rd Apr 20248:36 amRNSResult of General Meeting
8th Apr 20249:12 amRNSLitigation with Kyocera AVX settled
28th Mar 20245:00 pmRNSTotal Voting Rights
27th Mar 20248:22 amRNSSuspension of trading
27th Mar 20247:29 amRNSN04/24 - CAP-XX Limited - Suspension of trading
25th Mar 20247:00 amRNSResult of Retail Offer and Total Voting Rights
22nd Mar 20247:00 amRNSResult of Placing and Notice of General Meeting
21st Mar 20244:40 pmRNSREX Retail Offer
21st Mar 20244:35 pmRNSProposed Placing and Subscription to raise £2.0m
21st Mar 20249:00 amRNSLitigation Settlement Agreement with Tesla, Inc
19th Mar 202412:31 pmRNSHolding(s) in Company
18th Mar 20242:56 pmRNSHolding(s) in Company
15th Mar 202412:50 pmRNSHolding(s) in Company
15th Mar 20247:07 amRNSHolding(s) in Company
14th Mar 20247:00 amRNSUpdate on litigation
13th Mar 20247:00 amRNSCorporate Update
12th Mar 20247:00 amRNSRetirement of CFO
28th Feb 20247:00 amRNSUpdate on litigation and trading
19th Feb 20247:00 amRNSCessation of appeals process
1st Feb 20247:00 amRNSInterim Results
29th Jan 20247:00 amRNSUpdate on Patent Infringement
22nd Jan 202412:57 pmRNSChange of Joint Broker
10th Jan 20247:02 amRNSUpdate on IP and appeals process
29th Dec 20231:00 pmRNSTotal Voting Rights
21st Dec 20237:00 amRNSTrading Update
18th Dec 20237:00 amRNSUpdate on Patent Infringement
7th Dec 20237:00 amRNSCAP-XX finalises two new patents
5th Dec 20237:00 amRNSIssue of Shares and Director/PDMR Shareholdings
1st Dec 20237:00 amRNSUpdate re. R&D rebate and other matters
29th Nov 20237:00 amRNSHolding(s) in Company
22nd Nov 202311:29 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.